Selenia dimensions digital tomosynthesis system (Hologic Inc.) for diagnostic mammography
Record ID 32013000280
English
Authors' recommendations:
Breast cancer is the most frequently diagnosed cancer in women and the second leading cause of cancer death after lung cancer. According to the American Cancer Society, 230,480 new cases of invasive breast cancer were diagnosed in 2011, and approximately 39,520 deaths were attributed to the disease. Despite widespread use and acceptance of cancer screening, screen-film and fullfield digital mammography (FFDM) systems can miss approximately 20% of cancerous lesions. New breast imaging technologies are being developed to increase cancer detection rates and reduce unnecessary recalls, which cause patients to undergo unnecessary additional imaging, radiation exposure, and anxiety. Digital breast tomosynthesis (DBT) has been developed to improve cancer detection rate and reduce or eliminate problems associated with mammography, including image noise caused by overlapping of breast tissue (which may conceal or imitate cancer cells) and difficulties in imaging dense breast tissue.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
The report may be purchased from:http://www.hayesinc.com/hayes/crd/?crd=14596
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Carcinoma, Ductal, Breast
- Mammography
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2012 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.